Yu-Ting Ma Hong-Lan Yang Li Yan Fang Hua Dong-Guan Wang Guo-Ying Xu Yan Li Ying-Jie Xue Ye-Jun Qin Dan Sha Hao Ning Miao-Qing Zhao Zhi-Gang Yao
10.3389/pore.2022.1610638
Pathol Oncol Res
2022 Oct 21;28:1610638.
pd-1/pd-l1 immune checkpoint inhibitors immunotherapy lynch syndrome microsatellite instability urothelial carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36338826/
Carcinoma, Transitional Cell / drug therapy Colorectal Neoplasms / pathology Colorectal Neoplasms, Hereditary Nonpolyposis Urinary Bladder Neoplasms / drug therapy Urinary Bladder Neoplasms / genetics
Carcinoma, Transitional Cell / drug therapy Colorectal Neoplasms / pathology Colorectal Neoplasms, Hereditary Nonpolyposis Urinary Bladder Neoplasms / drug therapy Urinary Bladder Neoplasms / genetics Case Reports DNA Mismatch Repair Female Humans Immunotherapy Microsatellite Instability Programmed Cell Death 1 Receptor Programmed Cell Death 1 Receptor
PMC9633672
36338826
Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
2022